Stanford Cancer Institute, Stanford Medicine at Stanford University is a clinical research site located in Palo Alto, California, United States 94304.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Stanford Cancer Institute, Stanford Medicine at Stanford University has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Cutaneous Squamous Cell Carcinoma.
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford Cancer Institute, Stanford Medicine at Stanford University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford Cancer Institute, Stanford Medicine at Stanford University has 1 clinical trials on record, with 1 currently active. Their work covers Cutaneous Squamous Cell Carcinoma.
Stanford Cancer Institute, Stanford Medicine at Stanford University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.